Aspen Pharmacare (APNHY) Short Interest Ratio & Short Volume → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free APNHY Stock Alerts $12.60 +0.26 (+2.07%) (As of 05/15/2024) Add Compare Share Share Short InterestStock AnalysisChartDividendFinancialsHeadlinesShort InterestStock AnalysisChartDividendFinancialsHeadlinesShort Interest Aspen Pharmacare Short Interest DataCurrent Short Volume1,200 sharesPrevious Short Volume1,200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$14,328.00Short Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares446,252,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume100 sharesAverage Trading Volume471 sharesToday's Volume Vs. Average21% Short Selling Aspen Pharmacare ? Sign up to receive the latest short interest report for Aspen Pharmacare and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPNHY Short Interest Over TimeAPNHY Days to Cover Over TimeAPNHY Percentage of Float Shorted Over Time Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company Aspen Pharmacare Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,200 shares $14,328.00 No ChangeN/A1.7 $11.94 4/15/20241,200 shares $13,908.00 -64.7%N/A6 $11.59 3/31/20243,400 shares $39,100.00 No ChangeN/A11.3 $11.50 3/15/20243,400 shares $38,046.00 +100.0%N/A4.3 $11.19 2/29/20241,700 shares $17,238.00 No ChangeN/A8.5 $10.14 2/15/20241,700 shares $17,476.00 +6.3%N/A5.7 $10.28 Get the Latest News and Ratings for APNHY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024300 shares $3,255.00 -40.0%N/A0.8 $10.85 12/31/2023500 shares $5,485.00 -16.7%N/A1.9 $10.97 12/15/2023600 shares $6,264.00 +100.0%N/A1.2 $10.44 11/30/2023300 shares $2,949.75 +50.0%N/A0.8 $9.83 11/15/2023200 shares $1,912.00 +100.0%N/A0.3 $9.56 10/31/2023100 shares $909.00 No ChangeN/A0.3 $9.09 10/15/2023100 shares $918.00 -50.0%N/A0.1 $9.18 9/30/2023200 shares $1,848.00 +100.0%N/A0.2 $9.24 9/15/2023100 shares $834.80 -50.0%N/A0.3 $8.35 8/31/2023200 shares $1,820.00 No ChangeN/A0.2 $9.10 7/15/2023500 shares $4,900.00 +400.0%N/A1.3 $9.80 6/30/2023100 shares $977.00 No ChangeN/A1 $9.77 6/15/2023100 shares $996.00 No ChangeN/A0.3 $9.96 4/30/2023100 shares $973.25 No ChangeN/A0.3 $9.73 4/15/2023100 shares $1,005.00 No ChangeN/A0.5 $10.05 3/31/2023100 shares $1,029.00 -75.0%N/A0.3 $10.29 3/15/2023400 shares $3,752.20 +100.0%N/A0.2 $9.38 2/28/2023200 shares $1,634.30 No ChangeN/A0.4 $8.17 2/15/2023200 shares $1,656.40 No ChangeN/A0.4 $8.28 1/31/2023200 shares $1,737.50 No ChangeN/A0.4 $8.69 1/15/2023200 shares $1,654.00 +100.0%N/A0.1 $8.27 12/30/2022100 shares $802.50 -95.2%N/A0.1 $8.03 12/15/20222,100 shares $16,159.50 +950.0%N/A1.3 $7.70 11/30/2022200 shares $1,696.80 No ChangeN/A0.2 $8.48 11/15/2022200 shares $1,763.00 No ChangeN/A0.4 $8.82 10/31/2022200 shares $1,590.00 No ChangeN/A0.1 $7.95 10/15/2022200 shares $1,594.00 -33.3%N/A0.1 $7.97 9/30/2022300 shares $2,331.00 +50.0%N/A1 $7.77 9/15/2022200 shares $1,678.00 No ChangeN/A0.2 $8.39 8/31/2022200 shares $1,698.00 No ChangeN/A0.2 $8.49 8/15/2022200 shares $1,916.00 -33.3%N/A0.1 $9.58 7/31/2022300 shares $2,769.00 No ChangeN/A0.3 $9.23 7/15/2022300 shares $2,499.00 -25.0%N/A1 $8.33 6/30/2022400 shares $3,596.00 No ChangeN/A0.1 $8.99Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company APNHY Short Interest - Frequently Asked Questions What is Aspen Pharmacare's current short interest? Short interest is the volume of Aspen Pharmacare shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,200 shares of APNHY short. Learn More on Aspen Pharmacare's current short interest. What is a good short interest ratio for Aspen Pharmacare? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APNHY shares currently have a short interest ratio of 2.0. Learn More on Aspen Pharmacare's short interest ratio. How does Aspen Pharmacare's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Aspen Pharmacare: Hikma Pharmaceuticals PLC (0.84%), Sino Biopharmaceutical Limited (0.20%), Orion Oyj (0.00%), Zealand Pharma A/S (0.89%), GN Store Nord A/S (0.00%), Ramsay Health Care Limited (0.00%), Nihon Kohden Co. (0.00%), Sonic Healthcare Limited (0.00%), Sysmex Co. (0.00%), Eurofins Scientific SE (0.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aspen Pharmacare stock? Short selling APNHY is an investing strategy that aims to generate trading profit from Aspen Pharmacare as its price is falling. APNHY shares are trading up $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aspen Pharmacare? A short squeeze for Aspen Pharmacare occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APNHY, which in turn drives the price of the stock up even further. How often is Aspen Pharmacare's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APNHY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Hikma Pharmaceuticals Short Interest Data Sunny Optical Technology (Group) Short Interest Data Sino Biopharmaceutical Short Interest Data Orion Oyj Short Interest Data Zealand Pharma A/S Short Interest Data GN Store Nord A/S Short Interest Data Ramsay Health Care Short Interest Data Nihon Kohden Short Interest Data Sonic Healthcare Short Interest Data Sysmex Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:APNHY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford Club